BTK-IN-17 is a selective, orally active inhibitor of Brutons Tyrosine Kinase (BTK) with an inhibition concentration (IC50) value of 13.7 nM. It effectively reduces the expression of phosphorylated BTK at Tyrosine 223 (p-BTK Y223) and phosphorylated Phospholipase C Gamma 2 at Tyrosine 1217 (p-PLCgamma2 Y1217), demonstrating anti-inflammatory properties.
Molecular Weight:
465.51
Formula:
C26H23N7O2
Target:
Others|||BTK
T73303
* VAT and and shipping costs not included. Errors and price changes excepted
